NASDAQ:ABSI Absci (ABSI) Stock Price, News & Analysis $8.18 +0.60 (+7.92%) Closing price 11/18/2026 04:00 PM EasternExtended Trading$8.38 +0.20 (+2.49%) As of 11/18/2026 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Absci Stock (NASDAQ:ABSI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Absci alerts:Sign Up Key Stats Today's Range$7.60▼$8.7350-Day Range$7.47▼$12.1052-Week Range$2.24▼$12.54Volume5.66 million shsAverage Volume4.55 million shsMarket Capitalization$1.41 billionP/E RatioN/ADividend YieldN/APrice Target$14.90Consensus RatingModerate Buy Company Overview Absci Corporation is a biotechnology company that uses artificial intelligence and laboratory research to discover and develop biologic drugs. Its platform combines generative AI with experimental testing to design and evaluate potential drug candidates, including antibodies and other protein-based medicines. The company also works with pharmaceutical and biotechnology partners on drug discovery programs and advances its own pipeline of potential therapies. Its approach is intended to connect computational design with laboratory validation, helping assess whether designed molecules have useful properties. Founded in 2011 by Sean McClain, Absci is headquartered in Vancouver, Washington. McClain serves as the company’s chief executive officer.AI Generated. May Contain Errors. Read More Absci Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreABSI MarketRank™: 2.902452390735 of 5 starsAbsci scored higher than 58% of companies evaluated by MarketBeat, and ranked 641st out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingAbsci has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on no strong buy ratings, 11 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialAbsci has a consensus price target of $14.90, representing about 82.2% upside from its current price of $8.18.Amount of Analyst CoverageAbsci has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Absci's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Absci are expected to grow in the coming year, from ($0.76) to ($0.72) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Absci is -10.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Absci is -10.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAbsci has a P/B Ratio of 6.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted23.34% of the float of Absci has been sold short.Short Interest Ratio / Days to CoverAbsci has a short interest ratio ("days to cover") of 9.06.Change versus previous monthShort interest in Absci has recently decreased by 3.18%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAbsci does not currently pay a dividend.Dividend GrowthAbsci does not have a long track record of dividend growth. News and Social Media1.9 / 5News Sentiment-0.04 News SentimentAbsci has a news sentiment score of -0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 28 news articles for Absci this week, compared to 4 articles on an average week.Search InterestOnly 13 people have searched for ABSI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows11 people have added Absci to their MarketBeat watchlist in the last 30 days. This is an increase of 57% compared to the previous 30 days. Company Ownership1.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Absci insiders have not sold or bought any company stock.Percentage Held by Insiders10.52% of the stock of Absci is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.05% of the stock of Absci is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Absci's insider trading history. Receive ABSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABSI Stock News HeadlinesAbsci (NASDAQ:ABSI) Stock Price Down 9.6% After Analyst DowngradeNovember 18 at 1:52 AM | americanbankingnews.comAbsci (NASDAQ:ABSI) Stock Price Target Cut by GuggenheimNovember 18 at 1:18 AM | americanbankingnews.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. | Profits Run (Ad)Absci Corp. (ABSI) Gets Downgraded. Here’s How MuchNovember 16 at 9:29 PM | finance.yahoo.comH.C. Wainwright Keeps Their Buy Rating on AbSci (ABSI)November 15, 2026 | theglobeandmail.comAbsci (NASDAQ:ABSI) Price Target Raised to $15.00November 15, 2026 | americanbankingnews.comAbsci's (ABSI) Buy Rating Reiterated at BTIG ResearchNovember 15, 2026 | americanbankingnews.comAbsci (ABSI) Advances ABS 201 Plans, Is The 43% Discount Justified?November 13, 2026 | finance.yahoo.comSee More Headlines ABSI Stock Analysis - Frequently Asked Questions How have ABSI shares performed this year? Absci's stock was trading at $3.49 at the beginning of the year. Since then, ABSI shares have increased by 134.4% and is now trading at $8.18. How were Absci's earnings last quarter? Absci Corporation (NASDAQ:ABSI) announced its earnings results on Thursday, November, 12th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.19) by $0.00. The company had revenue of $304 thousand for the quarter, compared to the consensus estimate of $658 thousand. Absci had a negative trailing twelve-month return on equity of 61.60% and a negative net margin of 8,451.31%. Read the conference call transcript. When did Absci IPO? Absci (ABSI) raised $200 million in an IPO on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share. Who are Absci's major shareholders? Absci's top institutional shareholders include State Street Corp (4.93%), Marshall Wace LLP (1.13%), Goldman Sachs Group Inc. (0.93%) and Integral Health Asset Management LLC (0.76%). Insiders that own company stock include Phoenix Venture Partners Ii Lp, Sean Mcclain, Redmile Group, Llc, Andreas Busch, Zachariah Jonasson, Todd Bedrick and Menelas N Pangalos. View institutional ownership trends. How do I buy shares of Absci? Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Absci own? Based on aggregate information from My MarketBeat watchlists, some other companies that Absci investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Taiwan Semiconductor Manufacturing (TSM), CRISPR Therapeutics (CRSP), Recursion Pharmaceuticals (RXRX), Palantir Technologies (PLTR) and Marvell Technology (MRVL). Company Calendar Last Earnings11/12/2026Today11/18/2026Jefferies Global Healthcare Conference11/18/20269th Annual Evercore ISI HealthCONx Conference12/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (7m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ABSI's financial health is in the Green zone, according to TradeSmith. ABSI has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:ABSI CIK1672688 Webwww.absci.com Phone360-949-1041FaxN/AEmployees140Year Founded2011Price Target and Rating Average Price Target for Absci$14.90 High Price Target$20.00 Low Price Target$10.00 Potential Upside/Downside+82.2%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage12 Analysts Profitability EPS (Trailing Twelve Months)($0.79) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$115.18 million Net Margins-8,451.31% Pretax Margin-8,457.10% Return on Equity-61.60% Return on Assets-55.30% Debt Debt-to-Equity RatioN/A Current Ratio9.64 Quick Ratio9.64 Sales & Book Value Annual Sales$2.80 million Price / Sales504.68 Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book6.44Miscellaneous Outstanding Shares172,750,000Free Float154,573,000Market Cap$1.41 billion OptionableOptionable Beta2.22 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:ABSI) was last updated on 11/18/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Absci Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Absci With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.